See also this year's filing and all EDGAR filings for this company.
PDF Report 0001348362_2023_Lexaria_Bioscience_Corp.pdf
Logs
info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0001348362, Lexaria Bioscience Corp.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 6,977,516 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 315,505 |
3 | remainder_Assets | 540,906 |
4 | LiabilitiesCurrent | 194,036 |
5 | LiabilitiesNoncurrent | 7,401 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 71,841 |
8 | SellingGeneralAndAdministrativeExpense | 5,724,534 |
9 | ResearchAndDevelopmentExpense | 1,842,675 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 255,397 |
12 | remainder_NetIncome | 0 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 7,833,927 |
1 | Liabilities | 201,437 |
2 | Expenses | 7,639,050 |
3 | Revenues | 255,397 |
4 | StockholdersEquity | 7,632,490 |
5 | NetIncome | -7,383,653 |
6 | ComprehensiveNetIncome | -7,383,653 |
7 | BaseVar | 7,964,906 |
8 | EconomicCapitalRatio | 1.43 |